↓ Skip to main content

PLOS

The Prognostic Value of Epigenetic Silencing of p16 Gene in NSCLC Patients: A Systematic Review and Meta-Analysis

Overview of attention for article published in PLOS ONE, January 2013
Altmetric Badge

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
32 Mendeley
Title
The Prognostic Value of Epigenetic Silencing of p16 Gene in NSCLC Patients: A Systematic Review and Meta-Analysis
Published in
PLOS ONE, January 2013
DOI 10.1371/journal.pone.0054970
Pubmed ID
Authors

Zhang Lou-Qian, Yin Rong, Li Ming, Yang Xin, Jiang Feng, Xu Lin

Abstract

The prognostic significance of p16 promoter hypermethylation in patients with non-small cell lung cancer (NSCLC) is still controversial. This analysis presents pooled estimates of the association to better elucidate whether p16 methylation has a prognostic role in NSCLC.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 3%
Unknown 31 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 13%
Student > Doctoral Student 4 13%
Student > Bachelor 4 13%
Researcher 3 9%
Student > Master 3 9%
Other 9 28%
Unknown 5 16%
Readers by discipline Count As %
Medicine and Dentistry 9 28%
Agricultural and Biological Sciences 6 19%
Biochemistry, Genetics and Molecular Biology 5 16%
Social Sciences 2 6%
Environmental Science 1 3%
Other 4 13%
Unknown 5 16%